The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome

NCT ID: NCT06854146

Last Updated: 2025-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-01

Study Completion Date

2027-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study were to clarify how environmental factors such as air pollution affect the occurrence and development of gastric cancer; to identify patient-specific macrogenomic markers of gastric cancer; and to investigate the mechanism of gastric cancer development based on environmental factors and macrogenomic data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Cancers Air Pollution

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

gastric cancer group

patients diagnosed with gastric cancer

gastric cancer

Intervention Type DIAGNOSTIC_TEST

patients diagnosed with gastric cancer

control group

healthy participants

healthy

Intervention Type DIAGNOSTIC_TEST

healthy participants

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

gastric cancer

patients diagnosed with gastric cancer

Intervention Type DIAGNOSTIC_TEST

healthy

healthy participants

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age ≥ 18 years;
* patients with preoperative diagnosis of gastric cancer confirmed by pathologic biopsy;
* no chemotherapy, radiotherapy, targeted and immunotherapy, etc. before enrollment;
* willing to participate in the study and sign the informed consent form;
* complete clinical data.

Exclusion Criteria

* concurrent primary malignant tumor other than gastric cancer;
* patients with systemic diseases, such as severe cardiopulmonary;
* insufficiency, that affect the choice of treatment plan;
* not suitable for enrollment as assessed by the investigator;
* incomplete clinical data.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dong Peng

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dong Peng

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-444-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Survival Outcomes of Lung Cancer
NCT03647098 RECRUITING